XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2020 $ 1,200 $ 52,988,700 $ (41,627,800) $ 11,362,100
Balance at beginning of period (in shares) at Dec. 31, 2020 7,332,999      
Common stock discount amortization   24,700   24,700
Warrants underlying common stock issuance   (24,700)   (24,700)
Stock compensation expense   945,200   945,200
Net loss     (3,854,500) (3,854,500)
Balance at end of period at Mar. 31, 2021 $ 1,200 53,933,900 (45,482,300) 8,452,800
Balance at end of period (in shares) at Mar. 31, 2021 7,332,999      
Balance at beginning of period at Dec. 31, 2020 $ 1,200 52,988,700 (41,627,800) 11,362,100
Balance at beginning of period (in shares) at Dec. 31, 2020 7,332,999      
Net loss       (14,953,600)
Balance at end of period at Sep. 30, 2021 $ 9,300 94,083,200 (56,581,400) 37,511,100
Balance at end of period (in shares) at Sep. 30, 2021 15,477,518      
Balance at beginning of period at Mar. 31, 2021 $ 1,200 53,933,900 (45,482,300) 8,452,800
Balance at beginning of period (in shares) at Mar. 31, 2021 7,332,999      
Common stock discount amortization   24,900   24,900
Warrants underlying common stock issuance   (24,900)   (24,900)
Exercised stock options $ 100 125,300   125,400
Exercised stock options (in shares) 18,891      
Released restricted stock units (in shares) 35,610      
Stock compensation expense   1,268,600   1,268,600
Net loss     (4,974,300) (4,974,300)
Balance at end of period at Jun. 30, 2021 $ 1,300 55,327,800 (50,456,600) 4,872,500
Balance at end of period (in shares) at Jun. 30, 2021 7,387,500      
Common stock discount amortization   (85,500)   (85,500)
Common stock issuance net of issuance costs and discount amortization $ 8,000 36,144,400   36,152,400
Common stock issuance net of issuance costs and discount amortization (in shares) 8,000,000      
Warrants underlying common stock issuance   1,051,200   1,051,200
Common shares issued for Insilico Solutions LLC Membership Purchase Agreement   400,000   400,000
Common shares issued for Insilico Solutions LLC Membership Purchase Agreement (in shares) 50,189      
Restricted stock units issued for Insilico Solutions LLC Membership Purchase Agreement   140,000   140,000
Restricted stock units issued for Insilico Solutions LLC Membership Purchase Agreement (in shares) 33,177      
Released restricted stock units (in shares) 6,652      
Stock compensation expense   1,105,300   1,105,300
Net loss     (6,124,800) (6,124,800)
Balance at end of period at Sep. 30, 2021 $ 9,300 94,083,200 (56,581,400) 37,511,100
Balance at end of period (in shares) at Sep. 30, 2021 15,477,518      
Balance at beginning of period at Dec. 31, 2021 $ 9,300 94,527,000 (67,216,500) 27,319,800
Balance at beginning of period (in shares) at Dec. 31, 2021 15,488,516      
Common stock discount amortization   85,100   85,100
Warrants underlying common stock issuance   (85,100)   (85,100)
Released restricted stock units (in shares) 97,071      
Stock compensation expense   80,100   80,100
Net loss     (7,367,800) (7,367,800)
Balance at end of period at Mar. 31, 2022 $ 9,300 94,607,100 (74,584,300) 20,032,100
Balance at end of period (in shares) at Mar. 31, 2022 15,585,587      
Balance at beginning of period at Dec. 31, 2021 $ 9,300 94,527,000 (67,216,500) 27,319,800
Balance at beginning of period (in shares) at Dec. 31, 2021 15,488,516      
Net loss       (27,663,200)
Balance at end of period at Sep. 30, 2022 $ 9,300 95,154,500 (94,879,700) 284,100
Balance at end of period (in shares) at Sep. 30, 2022 15,843,191      
Balance at beginning of period at Mar. 31, 2022 $ 9,300 94,607,100 (74,584,300) 20,032,100
Balance at beginning of period (in shares) at Mar. 31, 2022 15,585,587      
Common stock discount amortization   85,900   85,900
Warrants underlying common stock issuance   (85,900)   (85,900)
Released restricted stock units (in shares) 253,525      
Stock compensation expense   184,200   184,200
Net loss     (8,435,100) (8,435,100)
Balance at end of period at Jun. 30, 2022 $ 9,300 94,791,300 (83,019,400) 11,781,200
Balance at end of period (in shares) at Jun. 30, 2022 15,839,112      
Common stock discount amortization   86,900   86,900
Warrants underlying common stock issuance   (86,900)   (86,900)
Released restricted stock units (in shares) 4,079      
Stock compensation expense   363,200   363,200
Net loss     (11,860,300) (11,860,300)
Balance at end of period at Sep. 30, 2022 $ 9,300 $ 95,154,500 $ (94,879,700) $ 284,100
Balance at end of period (in shares) at Sep. 30, 2022 15,843,191